Graves' disease and Graves' orbitopathy following COVID-19.
作者信息
Lanzolla G, Marcocci C, Marinò M
机构信息
Department of Clinical and Experimental Medicine, Endocrinology Unit II, University of Pisa and University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
出版信息
J Endocrinol Invest. 2021 Sep;44(9):2011-2012. doi: 10.1007/s40618-021-01576-7. Epub 2021 May 8.
Abstract
摘要
相似文献
1
Graves' disease and Graves' orbitopathy following COVID-19.新冠病毒感染后的格雷夫斯病和格雷夫斯眼眶病
J Endocrinol Invest. 2021 Sep;44(9):2011-2012. doi: 10.1007/s40618-021-01576-7. Epub 2021 May 8.
2
Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.接种 SARS-CoV-2 疫苗后的 Graves 眼病：六例患者报告。
J Endocrinol Invest. 2023 Mar;46(3):617-627. doi: 10.1007/s40618-022-01955-8. Epub 2022 Nov 15.
3
Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.用鼠促甲状腺激素受体质粒进行基因免疫可破坏自身免疫性甲状腺疾病和格雷夫斯眼病的鼠模型中的自身耐受性。
Clin Exp Immunol. 2018 Mar;191(3):255-267. doi: 10.1111/cei.13075. Epub 2017 Nov 17.
4
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.格雷夫斯病和格雷夫斯眼病患者血清中胰岛素样生长因子-1 受体（IGF-1R）抗体。
J Endocrinol Invest. 2019 Apr;42(4):471-480. doi: 10.1007/s40618-018-0943-8. Epub 2018 Aug 21.
5
Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves' disease.mRNA COVID-19 疫苗接种后伴 Graves 病病史患者出现胫前黏液水肿和甲状腺眼病。
Ann Endocrinol (Paris). 2024 Apr;85(2):100-103. doi: 10.1016/j.ando.2023.10.004. Epub 2023 Oct 20.
6
Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.严重 Graves 眼病患者长期低剂量抗甲状腺药物治疗期间 Graves 甲亢的持续控制。
Thyroid. 2011 Sep;21(9):951-6. doi: 10.1089/thy.2011.0039. Epub 2011 Aug 11.
7
8
Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.接种 SARS-CoV-2 mRNA 疫苗后 Graves 病的发病：病例报告及文献复习。
Front Public Health. 2021 Nov 23;9:778964. doi: 10.3389/fpubh.2021.778964. eCollection 2021.
9
Pathogenesis of Graves' disease focusing on Graves' ophthalmopathy.聚焦于格雷夫斯眼病的格雷夫斯病发病机制。
Endocr Regul. 2011 Oct;45(4):209-20. doi: 10.4149/endo_2011_04_209.
10
Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone Receptor.芬戈莫德通过调节针对促甲状腺激素受体的自身免疫反应改善实验性格雷夫斯病及相关眼病的转归。
Thyroid. 2019 Sep;29(9):1286-1301. doi: 10.1089/thy.2018.0754.
引用本文的文献
1
Thyroid disorders and COVID-19: a comprehensive review of literature.甲状腺疾病与2019冠状病毒病：文献综述
Front Endocrinol (Lausanne). 2025 May 19;16:1535169. doi: 10.3389/fendo.2025.1535169. eCollection 2025.
2
Graves' Disease: Is It Time for Targeted Therapy? A Narrative Review.格雷夫斯病：是时候进行靶向治疗了吗？一篇叙述性综述。
Medicina (Kaunas). 2025 Mar 13;61(3):500. doi: 10.3390/medicina61030500.
3
Concomitant Exacerbation of Graves Orbitopathy and Double-Seronegative Myasthenia Gravis after SARS-CoV-2 Infection.新型冠状病毒感染后格雷夫斯眼眶病与双血清阴性重症肌无力的合并加重
JCEM Case Rep. 2025 Jan 29;3(2):luaf019. doi: 10.1210/jcemcr/luaf019. eCollection 2025 Feb.
4
New-Onset Graves' Disease Induced by COVID-19: A Case Report and Literature Review.COVID-19诱发的新发格雷夫斯病：一例报告及文献综述
Cureus. 2024 Nov 6;16(11):e73122. doi: 10.7759/cureus.73122. eCollection 2024 Nov.
5
Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long COVID.了解新型冠状病毒感染后的自身免疫反应以及长期新冠的发病机制。
Med Rev (2021). 2024 May 27;4(5):367-383. doi: 10.1515/mr-2024-0013. eCollection 2024 Oct.
6
Hypophysitis in COVID-19: a systematic review.新型冠状病毒肺炎中的垂体炎：一项系统综述
Pituitary. 2024 Dec;27(6):874-888. doi: 10.1007/s11102-024-01462-4. Epub 2024 Oct 15.
7
Graves disease: latest understanding of pathogenesis and treatment options.格雷夫斯病：发病机制和治疗选择的最新认识。
Nat Rev Endocrinol. 2024 Nov;20(11):647-660. doi: 10.1038/s41574-024-01016-5. Epub 2024 Jul 22.
8
Post-COVID-19 Vaccination and Thyrotoxicosis (ASIA Syndrome): Single-Centre Experience from India with Review of Literature.新冠病毒病疫苗接种与甲状腺毒症（亚洲综合征）：来自印度的单中心经验及文献综述
Indian J Endocrinol Metab. 2023 Nov-Dec;27(6):524-529. doi: 10.4103/ijem.ijem_202_23. Epub 2024 Jan 11.
9
Thyroid dysfunction in COVID-19.COVID-19 相关甲状腺功能障碍。
Nat Rev Endocrinol. 2024 Jun;20(6):336-348. doi: 10.1038/s41574-023-00946-w. Epub 2024 Feb 12.
10
Thyroid Autoimmunity and SARS-CoV-2 Infection.甲状腺自身免疫与2019冠状病毒病感染
J Clin Med. 2023 Oct 5;12(19):6365. doi: 10.3390/jcm12196365.
Zotero 插件